APA (7th ed.) Citation

Lamers-Kok, N., Panella, D., Georgoudaki, A., Liu, H., Özkazanc, D., Kučerová, L., . . . Raimo, M. (2022). Natural killer cells in clinical development as non-engineered, engineered, and combination therapies. Journal of Hematology & Oncology, 15(1), 1. https://doi.org/10.1186/s13045-022-01382-5

Chicago Style (17th ed.) Citation

Lamers-Kok, Nina, Denise Panella, Anna-Maria Georgoudaki, Haiping Liu, Didem Özkazanc, Lucia Kučerová, Adil Doganay Duru, Jan Spanholtz, and Monica Raimo. "Natural Killer Cells in Clinical Development as Non-engineered, Engineered, and Combination Therapies." Journal of Hematology & Oncology 15, no. 1 (2022): 1. https://doi.org/10.1186/s13045-022-01382-5.

MLA (9th ed.) Citation

Lamers-Kok, Nina, et al. "Natural Killer Cells in Clinical Development as Non-engineered, Engineered, and Combination Therapies." Journal of Hematology & Oncology, vol. 15, no. 1, 2022, p. 1, https://doi.org/10.1186/s13045-022-01382-5.